MD517G2 - Metodă de tratare a febrei tifoide - Google Patents
Metodă de tratare a febrei tifoideInfo
- Publication number
- MD517G2 MD517G2 MD96-0034A MD960034A MD517G2 MD 517 G2 MD517 G2 MD 517G2 MD 960034 A MD960034 A MD 960034A MD 517 G2 MD517 G2 MD 517G2
- Authority
- MD
- Moldova
- Prior art keywords
- proteins
- treatment
- correction coefficient
- optimal
- body mass
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000037386 Typhoid Diseases 0.000 title abstract 2
- 201000008297 typhoid fever Diseases 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 230000035764 nutrition Effects 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 102000015335 Ku Autoantigen Human genes 0.000 abstract 1
- 108010025026 Ku Autoantigen Proteins 0.000 abstract 1
- 101100077717 Mus musculus Morn2 gene Proteins 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000037081 physical activity Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la terapie şi poate fi folosită în tratamentul pacienţilor cu deficit nutriţional în condiţii extreme.Metoda constă în faptul că tratamentul medicamentos se efectuează în paralel cu alimentaţia enterală cu hidrolizate de albumină, doza căreia va fi calculată folosind formula:Bopt.=2,07×Mopt.+2,07×Mopt.×(Kc+Ks+Kt) - (Bh-Bh×Ku), în care:Bopt. este cantitatea optimă de albumină, necesară bolnavilor cu febră tifoidă şi deficit nutriţional (g);2,07 este necesitatea optimă în albumină la 1 kg de masă corporală timp de 24 de ore la persoanele cu activitate fizică înaltă până la spitalizare (g);Mopt. este masa corporală optimă a omului (kg);Kc este coeficientul de corecţie conform factorilor climaterici;Ks este coeficientul de corecţie conform factorilor de stres;Kt este coeficientul de corecţie conform temperaturii corporale;Bh este cantitatea de albumină în dieta spitalicească (g);Ku este coeficientul de corecţie conform gradului de utilizare a albuminei.Metoda propusă de tratare permite obţinerea următorului rezultat tehnic: micşorarea duratei tratamentului, frecvenţei complicaţiilor şi recidivelor la bolnavii trataţi în condiţii extreme.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD96-0034A MD517G2 (ro) | 1996-12-08 | 1996-12-08 | Metodă de tratare a febrei tifoide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MD96-0034A MD517G2 (ro) | 1996-12-08 | 1996-12-08 | Metodă de tratare a febrei tifoide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD517F1 MD517F1 (ro) | 1996-04-30 |
| MD517G2 true MD517G2 (ro) | 1996-11-30 |
Family
ID=19738793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD96-0034A MD517G2 (ro) | 1996-12-08 | 1996-12-08 | Metodă de tratare a febrei tifoide |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD517G2 (ro) |
-
1996
- 1996-12-08 MD MD96-0034A patent/MD517G2/ro active IP Right Grant
Non-Patent Citations (2)
| Title |
|---|
| Васильев П.С. и др. Сочетанное применение препаратов парентерального белкового питания, энергетических компонентов и стимуляторов биосинтеза белка. Методические рекомендации. М., 1982, р. 30. * |
| Ляшенко Ю.И., Иванов А.И. Смешанные инфекции, Медицина, М. 1980, р. 81-85. * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD517F1 (ro) | 1996-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2116559A1 (en) | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases | |
| TW265265B (ro) | ||
| CA2243708A1 (en) | Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection | |
| CZ176495A3 (en) | The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes | |
| IE882091L (en) | Pharmaceutical compositions comprising sometostatin¹analogues | |
| Bao et al. | Twenty-item behavioral neurological assessment for normal newborns in 12 cities of China | |
| NO172043C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-2,3-butadienyl-triamioalkanderivater | |
| MY105798A (en) | Treatment of leukocyte dysfunction with gm-csf. | |
| West et al. | Diagnosis and treatment planning: a coordinated effort between oral and maxillofacial surgery and orthodontics | |
| CN1052403C (zh) | 活性离子钙制作方法 | |
| DE3470002D1 (en) | Use of l-fucose in the preparation of an inhalation composition and a process for preparing l-fucose | |
| DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
| CROSS | Benign parotid tumors | |
| CN1057001C (zh) | 一种治疗类风湿的纯中药胶囊 | |
| Clifford et al. | Occlusal splint prescription in the management of temporomandibular disorders | |
| UA31141A (uk) | Спосіб лікування алергічних станів | |
| JPH0722591B2 (ja) | 磁力温熱押圧健康器 | |
| CN1122702A (zh) | 气管炎、哮喘、肺肿安药物 | |
| RU94016196A (ru) | Способ лечения больных брюшным тифом | |
| CN1065403A (zh) | 痛经安 | |
| Schutzenberger | The drama of seriously ill patient | |
| RICO et al. | Harry H., aged eighteen months, was at birth unusually plump and vigorous, and for twelve months thereafter his | |
| ALBERT | Temporomandibular Joint Syndrome | |
| de W Kitcat | Practical Points in the Home Treatment of Tuberculosis | |
| MARBACH et al. | Temporomandibular Joint Syndrome-Reply |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Granted patent for invention | ||
| IF99 | Valid patent on 19990615 |
Free format text: EXPIRES: 20161208 |